08/20/2025
4:13 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
07/30/2025
7:03 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:50 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
3:50 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
07/01/2025
5:16 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
4:50 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:49 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
06/11/2025
6:43 PM | Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:45 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LENZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/11/2025
4:46 PM | Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | Drapkin Kimberlee C (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
3:19 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/07/2025
3:16 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:36 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form ARS | |
04/28/2025
3:30 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
3:33 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form DEFA14A | |
04/15/2025
7:37 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/14/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/09/2025
6:20 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:05 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
04/09/2025
3:06 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
04/08/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/08/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/04/2025
3:45 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025
3:46 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025
3:48 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/04/2025
3:53 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2025
3:45 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2025
3:38 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
5:10 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:26 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:20 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:22 PM | Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:24 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
6:55 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:08 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/06/2024
7:03 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
11/06/2024
7:06 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
11/06/2024
6:35 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:26 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
7:23 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:24 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:09 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
09/19/2024
4:04 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
3:09 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
MarketBeat All Access